Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2955-2958

  Marti, Sara ^a   Sánchez Céspedes, Javier ^a   Blasco, M Dolores ^b   Ruiz, Marc ^a   Espinal, Paula ^a   Alba, Verónica ^a   Fernández Cuenca, Felipe ^a,b,c   Pascual, Alvaro ^c   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; BACTERIAL ENZYME; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLINASE OXA 58; PIPERACILLIN; POLYMYXIN B; RIFAMPICIN; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ANALYSIS, DNA;

EID: 48749114996     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00072-08     Document Type: Article

References (28)

1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.
2. Beceiro, A., L. Dominguez, A. Ribera, J. Vila, F. Molina, R. Villanueva, J. M. Eiros, and G. Bou. 2004. Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3. Antimicrob. Agents Chemother. 48:1374-1378.
3. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Chu, Y. W., M. Afzal-Shah, E. T. S. Houang, M. F. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing: 17th informational supplement M100-S17. CLSI, Villanova, PA.
6. Dijkshoorn, L., A. Nemec, and M. Vaneechoutte. 2007. Identification of Acinetobacter genomic species by means of amplified rDNA restriction analysis (ARDRA). http://users.ugent.be/~mvaneech/ARDRA/ Acinetobacter.html.
7. Fernandez-Cuenca, F., L. Martinez-Martinez, M. C. Conejo, J. A. Ayala, E. J. Perea, and A. Pascual. 2003. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574.
8. Horrevorts, A., K. Bergman, L. Kollee, I. Breuker, I. Tjernberg, and L. Dijkshoorn. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572.
9. Lim, Y. M., K. S. Shin, and J. Kim. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905.
10. Liu, S. L., A. Hessel, and K. E. Sanderson. 1993. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for rRNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc. Natl. Acad. Sci. USA 90:6874-6878.
11. Marcos, M. A., M. T. Jimenez de Anta, and J. Vila. 1995. Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J. Med. Microbiol. 42:328-335.
12. Marque, S., L. Poirel, C. Heritier, S. Brisse, M. D. Blasco, R. Filip, G. Coman, T. Naas, and P. Nordmann. 2005. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol. 43:4885-4888.
13. Peleg, A. Y., J. M. Bell, A. Hofmeyr, and P. Wiese. 2006. Inter-country transfer of gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolyzing enzymes. J. Antimicrob. Chemother. 57:794-795.
14. Peleg, A. Y., C. Franklin, L. J. Walters, J. M. Bell, and D. W. Spelman. 2006. OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob. Agents Chemother. 50:399-400.
15. Poirel, L., E. Lebessi, C. Heritier, A. Patsoura, M. Foustoukou, and P. Nordmann. 2006. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece. Clin. Microbiol. Infect. 12:1138-1141.
16. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
17. OXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442-1448.
18. Poirel, L., S. Marque, C. Heritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208.
19. Ribera, A., F. Fernandez-Cuenca, A. Beceiro, G. Bou, L. Martinez-Martinez, A. Pascual, J. M. Cisneros, J. Rodriguez-Bano, J. Pachon, and J. Vila. 2004. Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3. Antimicrob. Agents Chemother. 48:1430-1432.
20. Ruiz, M., S. Marti, R. Fernandez-Cuenca, A. Pascual, and J. Vila. 2007. High prevalence of carbapenem-hydrolyzing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect. 13:1192-1198.
21. Salazar, D., V. B. Nievesm, M. Ruiz, J. Ruiz, J. Vila, A. Maria, and V. Elsa. 2007. Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Merida, Venezuela. Med. Sci. Monit. 13:BR89-BR94.
22. Vahaboglu, H., F. Budak, M. Kasap, G. Gacar, S. Torol, A. Karadenizli, F. Kolayli, and C. Eroglu. 2006. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J. Antimicrob. Chemother. 58:537-542.
23. Van, L. M., and H. Goossens. 2004. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 10:684-704.
24. Vaneechoutte, M., L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. De Vos, G. Claeys, and G. Verschraegen. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11-15.
25. Vila, J., S. Marti, and J. Sanchez-Cespedes. 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59:1210-1215.
26. Weaver, R. E., and L. A. Actis. 1994. Identification of Acinetobacter species. J. Clin. Microbiol. 32:1833.
27. Woodford, N., M. J. Ellington, J. M. Coelho, J. F. Turton, M. E. Ward, S. Brown, S. G. Amyes, and D. M. Livermore. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27:351-353.
28. VIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837-840.